Clinical Trial Update: Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of sunitinib malate and bevacizumab in kidney cancer and other solid tumors has completed; no trial outcomes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Sutent (sunitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer | Phase 1 | Status: COMPLETED